Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]

Table 1 Trial Schema

		Timing (data collection)
Identification & screening of eligible women (N = 16,040)*		Routine antenatal visit at 12-19 weeks (baseline data, Candida testing)
↓
Randomisation of women with asymptomatic Candida (n = 3208)		< 1 week after Candida testing
Clotrimazole ↓	Usual care ↓
Follow-up	Follow-up	28-32 weeks gestation (questionnaire)
↓	↓
Birth	Birth	Primary and secondary outcomes collected from obstetric database

* primary outcome data (preterm birth rates) will be obtained for all women screened regardless of the result

ISSN: 1471-2393